These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3355711)

  • 1. Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria.
    Michals K; Lopus M; Matalon R
    Biochem Med Metab Biol; 1988 Feb; 39(1):18-23. PubMed ID: 3355711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenylalanine metabolites in hyperphenylalaninemic children].
    Alvarez Domínguez L; Campistol Plana J; Ribes Rubio A; Riverola de Vecina AT
    An Esp Pediatr; 1992 May; 36(5):371-4. PubMed ID: 1616197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control.
    McMurry MP; Chan GM; Leonard CO; Ernst SL
    Am J Clin Nutr; 1992 May; 55(5):997-1004. PubMed ID: 1570811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal PKU: strategies for dietary treatment and monitoring compliance.
    Matalon R; Michals K; Gleason L
    Ann N Y Acad Sci; 1986; 477():223-30. PubMed ID: 3468827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylalanine metabolites, attention span and hyperactivity.
    Michals K; Matalon R
    Am J Clin Nutr; 1985 Aug; 42(2):361-5. PubMed ID: 4025205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
    Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
    Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.
    Mozrzymas R; Walkowiak D; Drzymała-Czyż S; Krzyżanowska-Jankowska P; Duś-Żuchowska M; Kałużny Ł; Walkowiak J
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine levels in PKU following minor surgery.
    Fiedler AE; Miller MJ; Bickel H; Cederbaum SD
    Am J Med Genet; 1982 Apr; 11(4):411-4. PubMed ID: 7091185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different phenotypes for phenylalanine hydroxylase deficiency.
    Güttler F; Hansen G
    Ann Clin Biochem; 1977 May; 14(3):124-34. PubMed ID: 869488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of phenylketonuria (PKU).
    McGill JJ
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():55-7. PubMed ID: 11400785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylketonuria--change in therapeutic strategies. Study of intellectual development and dietary compliance of young phenylketonuria patients].
    Weglage J; Fünders B; von Teeffelen-Heithoff A; Ullrich K
    Fortschr Med; 1993 Nov; 111(31):485-8. PubMed ID: 8276335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc and copper status of treated children with phenylketonuria.
    Acosta PB; Fernhoff PM; Warshaw HS; Hambidge KM; Ernest A; McCabe ER; Elsas LJ
    JPEN J Parenter Enteral Nutr; 1981; 5(5):406-9. PubMed ID: 7198157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia.
    Porta F; Mussa A; Zanin A; Greggio NA; Burlina A; Spada M
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):345-50. PubMed ID: 21336059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled diet in phenylketonuria may cause serum carnitine deficiency.
    Vilaseca MA; Briones P; Ferrer I; Campistol J; Riverola A; Castillo P; Ramon F
    J Inherit Metab Dis; 1993; 16(1):101-4. PubMed ID: 8487489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.